RXQ Compounding LLC is voluntarily recalling all lots of various compounded sterile medications because they may not be sterile or may contain visible crystals. The recall affects a wide range of injectable products including Ascorbic Acid (Vitamin C), Lidocaine, Fentanyl, and Midazolam, which were distributed nationwide. Using a non-sterile injectable medication can lead to serious, life-threatening infections, while crystallized products can cause blockages in blood vessels or other severe reactions.
The lack of sterility assurance and the presence of crystallization in these injectable drugs pose a medium risk of serious infection or vascular damage. While no injuries have been reported to date, these defects can cause localized inflammation, systemic infection, or organ damage if injected into a patient.
Voluntary recall of all lots within expiry.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.